Search Results - "E.D., Aymong"

IS ST-SEGMENT DEPRESSION EQUIVALENT TO ST-SEGMENT ELEVATION IN PATIENTS PRESENTING WITH OUT-OF-HOSPITAL CARDIAC ARREST? by Cheung, C.C, Habibi, M, Grunau, B, Aymong, E.D, Boone, R, Deyell, M.W, Shephard, S, Christenson, J.M, Taylor, C.M, Ramanathan, K

Get full text

118 ECGS Pre and Early Post Primary PCI : Important Predictor of In-Hospital Adverse Outcomes in STEMI Population by Chou, A.Y, Ramanathan, K, Gao, M.S, Chan, S, Aymong, E.D, Saw, J, Imrie, J, Orenstein, T, Wong, G.C

Get full text

Radiocontrast-Induced Acute Renal Failure—Impact beyond the Acute Phase: Contrast-Induced Nephropathy after Percutaneous Coronary Interventions in Relation to Chronic Kidney Disease and Hemodynamic Variables. Am J Cardiol 95 13–19, 2005 by G., Dangas, I., Iakovou, E., Nikolsky, E.D., Aymong, G.S., Mintz, N.N., Kipshidze, A.J., Lansky, I., Moussa, G.W., Stone, J.W., Moses, M.B., Leon, R., Mehran

Get full text

Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an antithrombotic regimen of aspirin alone) study by Mehran, R, Aymong, E.D, Ashby, D.T

Get full text

A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention by Mehran, R., Aymong, E.D., Nikolsky, E.

Get full text

Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial by Nikolsky, E., Aymong, E.D., Halkin, A.

Get full text